For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
If you continue without changing your cookie settings, we'll assume you’re happy with this.
When you replace a component of an FDA cleared or approved diagnostics kit with a recombinant monoclonal antibody from Abcam, we'll develop the antibody for you at no charge.
Replacing a kit component
Changing a diagnostics kit component is always painful: it entails revalidation of the kit and in most cases a resubmission with the FDA.
However, sometimes this cannot be avoided. If the analytical performance of your detection antibody no longer keeps up with other assays, if you have issues sourcing polyclonal antibodies or serum, or if your immunoassay shows unacceptable lot-to-lot variation then you need to change the antibody in your kit.
Whatever your reason for needing to switch antibodies, ensure the future performance and reproducibility of your detection antibody by switching to a recombinant monoclonal antibody from Abcam.
We'll develop a monoclonal antibody for you at no charge
To ease the pain of replacing a kit component, we will use our antibody expertise to develop a monoclonal antibody and we will waive the development costs if you use it as a component of a current kit. See full conditions below.
Why work with us?
When you work with us, you'll gain access to multiple industry-leading platforms, significantly increasing your chances of finding the right antibody for your application:
Our experts have successfully concluded more than 3,000 custom projects and are looking forward to supporting you over the full length of your development program. Please contact us at firstname.lastname@example.org.
In order to qualify for free antibody development, you must replace a component of an FDA cleared or approved diagnostic kit with an Abcam antibody. Abcam will develop the monoclonal antibody for you at no additional charge – a value from a few thousand dollars to tens of thousands of dollars. Abcam reserves the right to review and reject projects on a case-by-case basis.